{"protocolSection":{"identificationModule":{"nctId":"NCT06479421","orgStudyIdInfo":{"id":"2023-08-003"},"organization":{"fullName":"Samsung Medical Center","class":"OTHER"},"briefTitle":"A Clinical Study for Developing Artificial Intelligence(AI)-Based Clustering Model for Personalized Medicine in Acute Respiratory Failure","officialTitle":"A Clinical Study for Developing AI-based Clustering Model for Personalized Medicine in Acute Respiratory Failure: Single Center, Prospective Cohort Study"},"statusModule":{"statusVerifiedDate":"2024-06","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2023-08-14","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2025-02-28","type":"ESTIMATED"},"completionDateStruct":{"date":"2025-02-28","type":"ESTIMATED"},"studyFirstSubmitDate":"2024-06-24","studyFirstSubmitQcDate":"2024-06-24","studyFirstPostDateStruct":{"date":"2024-06-28","type":"ACTUAL"},"lastUpdateSubmitDate":"2024-06-24","lastUpdatePostDateStruct":{"date":"2024-06-28","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Ryoung-Eun Ko","investigatorTitle":"Clinical assistant professor","investigatorAffiliation":"Samsung Medical Center"},"leadSponsor":{"name":"Samsung Medical Center","class":"OTHER"},"collaborators":[{"name":"Ministry of Science and ICT, Republic of Korea","class":"UNKNOWN"}]},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"We will prospectively collect clinical information to develop a clustering analysis model and confirm phenotype for patients with acute respiratory failure who admit to the intensive care unit and require oxygen supply beyond a high flow nasal cannula, and a control group without acute respiratory failure. and clinical characteristics and prognosis will be compared."},"conditionsModule":{"conditions":["Acute Respiratory Failure"],"keywords":["phenotyping","clustering analysis"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":false,"designInfo":{"observationalModel":"COHORT","timePerspective":"PROSPECTIVE"},"bioSpec":{"retention":"SAMPLES_WITHOUT_DNA","description":"1. Blood sample collection\n\n   : Within 24 hours after admission to the intensive care unit, and 2 to 5 days after admission to the intensive care unit, 18 ml of blood is collected in an ethylenediaminetetraacetic acid(EDTA) tube once (a total of 2 times, 36 ml) to analyze the following.\n   * Interleukin(IL)-6, IL-8, tumor necrosis factor receptor-1 levels, etc. will be checked.\n   * If the planned sample collection time has passed after admission to the intensive care unit or if blood sample collection is difficult due to quarantine, etc., this can be omitted.\n2. Broncho-Alveolar Lavage(BAL) fluid sample collection\n\n   * Only for those subjects who undergo BAL during the treatment process, 5ml of BAL fluid will be collected and analyzed for the following.\n\n     * IL-1Î², IL-6, IL-8, Kerbs von Lungren-6, Plasminogen activator inhibitor-1, etc. will be checked."},"enrollmentInfo":{"count":250,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Acute Respiratory Failure group","description":"Among patients admitted to the internal medicine intensive care unit at Samsung Seoul Hospital, if all of the following conditions are met:\n\n1. Age 18 or older\n2. Patients who require treatment with high flow nasal cannula (HFNC), non-invasive ventilation (NIV (BIPAP or CPAP)), or mechanical ventilation (MV) due to acute respiratory failure."},{"label":"Control group","description":"For comparative analysis, among patients admitted to the internal medicine intensive care unit at Samsung Seoul Hospital who meet all of the following conditions, they are registered as a control group with the consent of the subjects and undergo the same research procedure.\n\n1. Age 18 or older\n2. Patients who do not require high flow nasal cannula (HFNC), non-invasive ventilation (NIV (BIPAP or CPAP)), or mechanical ventilation (MV) treatment"}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Hospital Mortality","description":"clinical outcomes - Hospital Mortality","timeFrame":"From date of admission until the date of hospital discharge or date of death from any cause, whichever came first, assessed up to 1 year"}],"secondaryOutcomes":[{"measure":"ICU Mortality","description":"clinical outcomes - ICU Mortality","timeFrame":"From date of ICU admission until the date of ICU discharge or date of death from any cause, whichever came first, assessed up to 6 months"},{"measure":"Hospital length of stay","description":"clinical outcomes - Hospital length of stay","timeFrame":"From date of hospital admission until the date of hospital discharge, assessed up to 1 years"},{"measure":"ICU length of stay","description":"clinical outcomes - ICU length of stay","timeFrame":"From date of ICU admission until the date of ICU discharge, assessed up to 6 months"}]},"eligibilityModule":{"eligibilityCriteria":"# Inclusion Criteria:\n\n- Acute Respiratory Failure group\n\nAmong patients admitted to the internal medicine intensive care unit at Samsung Seoul Hospital, if all of the following conditions are met:\n\n1) Age 18 or older 2) Patients who require treatment with high flow nasal cannula (HFNC), non-invasive ventilation (NIV (BIPAP or CPAP)), or mechanical ventilation (MV) due to acute respiratory failure.\n\n- control group For comparative analysis, among patients admitted to the internal medicine intensive care unit at Samsung Seoul Hospital who meet all of the following conditions, they are registered as a control group with the consent of the subjects and undergo the same research procedure.\n\n1. Age 18 or older\n2. Patients who do not require high flow nasal cannula (HFNC), non-invasive ventilation (NIV (BIPAP or CPAP)), or mechanical ventilation (MV) treatment\n\n   * Exclusion Criteria:\n\nIf any of the following criteria applies, you will not be permitted to participate in this clinical trial.\n\n1. Patients 48 hours after oxygen treatment (HFNC, NIV (BIPAP or CPAP), MV)\n2. Patients transferred from another hospital\n3. Patients with limitations in treatment","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"1. Patients with acute respiratory failure admitted to the internal medicine intensive care unit of Samsung Seoul Hospital 1) Age 18 or older 2) Patients who require treatment with high flow nasal cannula (HFNC), non-invasive ventilation (NIV (BIPAP or CPAP)), or mechanical ventilation (MV) due to acute respiratory failure.\n2. The following patients (control group) admitted to the internal medicine intensive care unit of Samsung Seoul Hospital 1) Age 18 or older 2) Patients who do not require high flow nasal cannula (HFNC), non-invasive ventilation (NIV (BIPAP or CPAP)), or mechanical ventilation (MV) treatment","samplingMethod":"NON_PROBABILITY_SAMPLE"},"contactsLocationsModule":{"centralContacts":[{"name":"Ryoung Eun Ko, MD, PhD","role":"CONTACT","phone":"+82-2-3410-6399","email":"koryoungeun@gmail.com"}],"locations":[{"facility":"Samsung Medical Center","status":"RECRUITING","city":"Seoul","state":"Gangnam","zip":"06351","country":"Korea, Republic of","contacts":[{"name":"Hye Rim Chung","role":"CONTACT","phone":"+82-2-3410-6399","email":"hyerim37.jeong@samsung.com"}],"geoPoint":{"lat":37.566,"lon":126.9784}}]},"ipdSharingStatementModule":{"ipdSharing":"UNDECIDED"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-07-01"},"conditionBrowseModule":{"meshes":[{"id":"D000012131","term":"Respiratory Insufficiency"},{"id":"D000012128","term":"Respiratory Distress Syndrome"}],"ancestors":[{"id":"D000012120","term":"Respiration Disorders"},{"id":"D000012140","term":"Respiratory Tract Diseases"},{"id":"D000008171","term":"Lung Diseases"}],"browseLeaves":[{"id":"M14968","name":"Respiratory Insufficiency","asFound":"Respiratory Failure","relevance":"HIGH"},{"id":"M16355","name":"Syndrome","relevance":"LOW"},{"id":"M14965","name":"Respiratory Distress Syndrome","asFound":"Acute Respiratory Failure","relevance":"HIGH"},{"id":"M14964","name":"Respiratory Distress Syndrome, Newborn","relevance":"LOW"},{"id":"M14957","name":"Respiration Disorders","relevance":"LOW"},{"id":"M14977","name":"Respiratory Tract Diseases","relevance":"LOW"},{"id":"M11168","name":"Lung Diseases","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"},{"id":"T4927","name":"Respiratory Distress Syndrome, Infant","relevance":"LOW"},{"id":"T192","name":"Acute Respiratory Distress Syndrome","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC08","name":"Respiratory Tract (Lung and Bronchial) Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"BC16","name":"Diseases and Abnormalities at or Before Birth"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}